CRL-10609 MMQ 大鼠垂體瘤細胞，ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞|,細胞庫管理規(guī)范,提供的細胞株背景清楚,提供參考文獻優(yōu)培養(yǎng)條件
CRL-10609 MMQ 大鼠垂體瘤細胞 的詳細介紹
CRL-10609
| ATCC® Number: | CRL-10609™ | Price: | $438.00 |
| Designations: | MMQ |
|
| | Depositors: | University of Virginia Patent Foundation |
|
| | Biosafety Level: | 1 |
|
| | Shipped: | frozen |
|
| | Medium & Serum: | See Propagation |
|
| | Growth Properties: | suspension |
|
| | Organism: | Rattus norvegicus （rat） |
|
| | Morphology: | epithelial
|
|
| | Source: | Organ: pituitary
Disease: tumor |
|
| | Cellular Products: | prolactin |
|
| | Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | | |
|
| | Receptors: | dopamine |
|
| | Tumorigenic: | No |
|
| | Age: | 5 days |
|
| | Comments: | The cells secrete prolactin and express functional dopamine receptors [U.S. Patent 5,510,260]. |
|
| | Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated F-12K Medium, Catalog No. 30-2004. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 2.5% horse serum to a final concentration of 15%
Atmosphere: air, 95%; carbon dioxide （CO2）, 5%
Temperature: 37.0°C
DGrowth Conditions: The line grows as clumps of cells in suspension.
|
|
| | Subculturing: | Protocol: Cultures can be maintained by addition or replacement of medium. Establish new cultures at 2 X 10（5） viable cells/ml and maintain between 1 X 10（5） and 1 X 10（6） cells/ml.
Medium Renewal: Every 2 days |
|
| | Preservation: | Freeze medium: culture medium, 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor phase |
|
| | Doubling Time: | 24 to 48 hrs |
|
| | Related Products: | Recommended medium （without the additional supplements or serum described under ATCC Medium）:ATCC 30-2004 recommended serum:ATCC 30-2020 recommended serum:ATCC 30-2040 Cell culture tested DMSO:ATCC 4-X |
|
| | References: | 22090: MacLeod RM, et al. Prolactin secreting cell line and method of obtaining the same. US Patent 5,510,260 dated Apr 23 1996 |
|
|
